27- Physician-Executive Series: Olivia Cavlan, MD (Alchemab)

What kind of opportunities medical students have if they don’t want a traditional medical career? Why is it important to think about medical training as a platform, rather than a predetermined path? In this episode, we answer all of these questions and more, with our guest, Olivia Cavlan MD.

Olivia is Chief Corporate Development and Strategy Officer at Alchemab Therapeutics Ltd, a biotech company developing novel products for patients with hard-to-treat diseases by harnessing the power of naturally protective antibodies.

Olivia holds an MD in Medicine and a BSc in Pharmacology from Bristol University where she graduated with the top First Class Honors.